Doyle Anthony
SEC insider (Form 3/4/5 filer). CIK 0001808688. Chief Financial Officer at BIOCRYST PHARMACEUTICALS INC (BCRX). 3 reported Form 4/5 transactions since Sep 2024; latest on Dec 19, 2024. Located in DURHAM, NC.
Companies Doyle Anthony has filed insider reports for
- BIOCRYST PHARMACEUTICALS INC (BCRX): Officer, Chief Financial Officer
Doyle Anthony
CIK: 0001808688
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (33.3%)
Compensation grants
Other (G, F, J, C, D, …)2 (66.7%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
BCRX
BIOCRYST PHARMACEUTICALS INC
Officer